Creotech Instruments (WAR:CRI) Operating Income: zł11.5 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:CRI Creotech Instruments SA WAR:CRI
76 GF Score
Price zł786.00
GF Value zł954.74
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Creotech Instruments Operating Income?

Creotech Instruments WAR:CRI +4.80% 76 Operating Income is zł11.5 Mil as of Mar. 2026. GuruFocus rates WAR:CRI with a GF Score™ of 76/100 and a GF Value™ of zł954.74 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Creotech Instruments's Operating Income for the three months ended in Mar. 2026 was zł-10.4 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was zł11.5 Mil.

Warning Sign:

Creotech Instruments SA had lost money in 75% of the time over the past 12quarters.

Operating Margin % is calculated as Operating Income divided by its Revenue. Creotech Instruments's Operating Income for the three months ended in Mar. 2026 was zł-10.4 Mil. Creotech Instruments's Revenue for the three months ended in Mar. 2026 was zł16.8 Mil. Therefore, Creotech Instruments's Operating Margin % for the quarter that ended in Mar. 2026 was -62.13%.

Creotech Instruments's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Creotech Instruments's annualized ROC % for the quarter that ended in Mar. 2026 was -15.42%. Creotech Instruments's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -98.75%.


Creotech Instruments  (WAR:CRI) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Creotech Instruments's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-41.792 * ( 1 - 17.38% )/( (214.537 + 233.315)/ 2 )
=-34.5285504/223.926
=-15.42 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Creotech Instruments's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-39.38/( ( (38.659 + max(-45.926, 0)) + (41.102 + max(-39.171, 0)) )/ 2 )
=-39.38/( ( 38.659 + 41.102 )/ 2 )
=-39.38/39.8805
=-98.75 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(23.36 + 19.842 + 25.378) - (26.49 + 0 + 88.016)
=-45.926

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(35.961 + 18.868 + 21.581) - (19.452 + 0 + 96.129)
=-39.171

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Creotech Instruments's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-10.448/16.816
=-62.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Creotech Instruments Operating Income Related Terms


Creotech Instruments Operating Income Historical Data

* Premium members only.

The historical data trend for Creotech Instruments's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creotech Instruments Operating Income Chart

Creotech Instruments Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Income
Get a 7-Day Free Trial -1.28 -8.28 -16.51 -22.45 24.87

Creotech Instruments Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.97 1.02 -8.74 29.62 -10.45
WAR:CRI
76GF Score
Creotech Instruments SA WAR:CRI
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Creotech Instruments Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł11.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of zł11.5 Mil mean?
Creotech Instruments (WAR:CRI) has a Operating Income of zł11.5 Mil as of Mar. 2026. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Creotech Instruments and its competitors.
Is Creotech Instruments' Operating Income too high?
Creotech Instruments' current Operating Income is zł11.5 Mil. Overall, Creotech Instruments has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Creotech Instruments' Operating Income compare to SPCX and GE?
Creotech Instruments' Operating Income of zł11.5 Mil can be compared against companies in the Aerospace & Defense industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for an Aerospace & Defense company?
A good Operating Income depends on the Aerospace & Defense industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Creotech Instruments and its competitors. Creotech Instruments's current Operating Income is zł11.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creotech Instruments stock overvalued right now?
Based on GuruFocus' analysis, Creotech Instruments (WAR:CRI) is currently considered Modestly Undervalued. The stock's GF Value™ is zł954.74, compared to a current price of zł786.00 — trading 17.7% below its estimated fair value. The current Operating Income is zł11.5 Mil. Creotech Instruments' overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Creotech Instruments (WAR:CRI), the current Operating Income is zł11.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Creotech Instruments (WAR:CRI) Overvalued in 2026?

Based on GuruFocus' analysis, Creotech Instruments stock appears to be undervalued. The current stock price of zł786.00 is trading 17.7% below its estimated GF Value™ of zł954.74. GuruFocus considers Creotech Instruments to be Modestly Undervalued.

Key valuation signals for WAR:CRI:

  • Operating Income: zł11.5 Mil
  • GF Value™: zł954.74 vs. price of zł786.00 (17.7% below fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the WAR:CRI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Creotech Instruments Business Description

Other Exchanges 5OB:Germany
Address Gen. L. Okulickiego 7/9, Piaseczno, POL, 05-500
Creotech Instruments SA is a provider of advanced space technologies, specialized electronics, and hardware with global applications in areas such as quantum computers, quantum cryptography, quantum physics, and high energy physics laboratories. Its five primary business segments are: NewSpace dedicated to developing a satellite platform and its components; Earth Observation dedicated to developing Earth Observation systems and UAV technology (Unmanned Aerial Vehicle); Science dedicated to developing specialized electronics and components for quantum computers and time synchronization systems; Production dedicated to the manufacture of electronics; ESA Projects dedicated chiefly to projects carried in partnership with or/and commissioned by the European Space Agency (ESA).
76GF Score

Get the complete analysis for WAR:CRI

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł786.00
Price
zł954.74
GF Value